The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL - PubMed (original) (raw)
The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL
M R Wills et al. J Virol. 1996 Nov.
Abstract
Cytotoxic T lymphocytes (CTL) appear to play an important role in the control of human cytomegalovirus (HCMV) in the normal virus carrier: previous studies have identified peripheral blood CD8+ CTL specific for the HCMV major immediate-early gene product (IE1) and more recently, by bulk culture and cloning techniques, have identified CTL specific for a structural gene product, the lower matrix protein pp65. In order to determine the relative contributions of CTL which recognize the HCMV proteins IE1, pp65, and glycoprotein B (gB) to the total HCMV-specific CTL response, we have used a limiting-dilution analysis system to quantify HCMV-specific CTL precursors with different specificities, allowing the antigenic specificity of multiple short-term CTL clones to be assessed, in a group of six healthy seropositive donors. All donors showed high frequencies of HCMV-specific major histocompatibility complex-restricted CTL precursors. There was a very high frequency of CTL specific for pp65 (lower matrix protein); IE1-specific CTL were also detectable at lower frequencies in three of five donors, while CTL directed to gB were undetectable. A pp65 gene deletion mutant of HCMV was then used to estimate the contribution of pp65-specific CTL to the total HCMV-specific CTL response; this showed that between 70 and 90% of all CTL recognizing HCMV-infected cells were pp65 specific. Analysis of the peptide specificity of pp65-specific CTL showed that some donors have a highly focused response recognizing a single peptide; the T-cell receptor Vbeta gene usage in these two donors was shown to be remarkably restricted, with over half of the responding CD8+ T cells utilizing a single Vbeta gene rearrangement. Other subjects recognized multiple pp65 peptides: nine new pp65 CTL peptide epitopes were defined, and for five of these the HLA-presenting allele has been identified. All four of the HLA A2 donors tested in this study recognized the same peptide. This apparent domination of the CTL response to HCMV during persistent infection by a single structural protein, irrespective of major histocompatibility complex haplotype, is not clearly described for other persistent virus infections, and the mechanism requires further investigation.
Similar articles
- Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
Rohrlich PS, Cardinaud S, Lulè J, Montero-Julian FA, Prodhomme V, Firat H, Davignon JL, Perret E, Monseaux S, Necker A, Michelson S, Lemonnier FA, Charneau P, Davrinche C. Rohrlich PS, et al. Hum Immunol. 2004 May;65(5):514-22. doi: 10.1016/j.humimm.2004.02.018. Hum Immunol. 2004. PMID: 15172452 - Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs.
Gyulai Z, Endresz V, Burian K, Pincus S, Toldy J, Cox WI, Meric C, Plotkin S, Gönczöl E, Berencsi K. Gyulai Z, et al. J Infect Dis. 2000 May;181(5):1537-46. doi: 10.1086/315445. Epub 2000 May 15. J Infect Dis. 2000. PMID: 10823751 - The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB.
Lilja AE, Mason PW. Lilja AE, et al. Vaccine. 2012 Nov 19;30(49):6980-90. doi: 10.1016/j.vaccine.2012.09.056. Epub 2012 Oct 3. Vaccine. 2012. PMID: 23041121 Review. - Multifaceted evasion of the interferon response by cytomegalovirus.
Marshall EE, Geballe AP. Marshall EE, et al. J Interferon Cytokine Res. 2009 Sep;29(9):609-19. doi: 10.1089/jir.2009.0064. J Interferon Cytokine Res. 2009. PMID: 19708810 Free PMC article. Review.
Cited by
- T cell responses and clinical symptoms among infants with congenital cytomegalovirus infection.
Medoro AK, Dhital R, Sánchez PJ, Flint K, Graber B, Pifer T, Crisan R, Ray WC, Phelps CC, Honegger JR, Peng J, Findlen U, Malhotra P, Adunka O, Shimamura M. Medoro AK, et al. JCI Insight. 2024 Sep 24;9(18):e171029. doi: 10.1172/jci.insight.171029. JCI Insight. 2024. PMID: 39315550 Free PMC article. - IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine release.
Schardt JS, Walseng E, Le K, Yang C, Shah P, Fu Y, Alam K, Kelton CR, Gu Y, Huang F, Lin J, Liu W, Dippel A, Zhang H, Mulgrew K, Pryts S, Chennupati V, Chen HC, Denham J, Chen X, Pradhan P, Wu Y, Hardman C, Zhao C, Kierny M, Song Y, Dovedi SJ, Cemerski S, Mazor Y. Schardt JS, et al. MAbs. 2024 Jan-Dec;16(1):2395499. doi: 10.1080/19420862.2024.2395499. Epub 2024 Aug 28. MAbs. 2024. PMID: 39205483 Free PMC article. - Immunomonitoring via ELISPOT Assay Reveals Attenuated T-Cell Immunity to CMV in Immunocompromised Liver-Transplant Patients.
Traska AK, Nowacki TM, Vollenberg R, Rennebaum F, Meier JA, Schomacher T, Reinartz Groba SN, Fischer J, Trebicka J, Tepasse PR. Traska AK, et al. Cells. 2024 Apr 24;13(9):741. doi: 10.3390/cells13090741. Cells. 2024. PMID: 38727277 Free PMC article. - Diverse cytomegalovirus US11 antagonism and MHC-A evasion strategies reveal a tit-for-tat coevolutionary arms race in hominids.
Zimmermann C, Watson GM, Bauersfeld L, Berry R, Ciblis B, Lan H, Gerke C, Oberhardt V, Fuchs J, Hofmann M, Freund C, Rossjohn J, Momburg F, Hengel H, Halenius A. Zimmermann C, et al. Proc Natl Acad Sci U S A. 2024 Feb 27;121(9):e2315985121. doi: 10.1073/pnas.2315985121. Epub 2024 Feb 20. Proc Natl Acad Sci U S A. 2024. PMID: 38377192 Free PMC article. - Cytomegalovirus Cell-Mediated Immunity: Ready for Routine Use?
Bestard O, Kaminski H, Couzi L, Fernández-Ruiz M, Manuel O. Bestard O, et al. Transpl Int. 2023 Nov 7;36:11963. doi: 10.3389/ti.2023.11963. eCollection 2023. Transpl Int. 2023. PMID: 38020746 Free PMC article. Review.
References
- J Exp Med. 1987 Feb 1;165(2):408-16 - PubMed
- Immunogenetics. 1995;41(4):178-228 - PubMed
- J Neuroimmunol. 1989 Feb;21(2-3):205-12 - PubMed
- Eur J Immunol. 1990 Mar;20(3):523-31 - PubMed
- Curr Top Microbiol Immunol. 1990;154:189-220 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials